MEDNAX ($MD) posted quarterly earnings results for Q4 2025 on Thursday, February 19th. The company reported earnings of $0.50 per share, missing estimates of $0.56 by $0.06. The company also reported revenue of $493,770,000, missing estimates of $500,814,840 by $-7,044,840.
You can see Quiver Quantitative's $MD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDNAX Insider Trading Activity
MEDNAX insiders have traded $MD stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MD stock by insiders over the last 6 months:
- MARK S ORDAN (Chief Executive Officer) sold 23,000 shares for an estimated $515,430
- MICHAEL A. RUCKER sold 10,478 shares for an estimated $240,994
- LAURA A LINYNSKY sold 10,000 shares for an estimated $216,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDNAX Hedge Fund Activity
We have seen 146 institutional investors add shares of MEDNAX stock to their portfolio, and 159 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. added 1,229,505 shares (+inf%) to their portfolio in Q4 2025, for an estimated $26,299,111
- CASPIAN CAPITAL LP removed 1,115,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $23,849,850
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 1,032,351 shares (+inf%) to their portfolio in Q4 2025, for an estimated $22,081,987
- AMERICAN CENTURY COMPANIES INC added 1,015,159 shares (+37.8%) to their portfolio in Q4 2025, for an estimated $21,714,251
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 713,264 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $15,256,716
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 639,400 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,676,766
- BOSTON PARTNERS removed 630,251 shares (-44.1%) from their portfolio in Q4 2025, for an estimated $13,481,068
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MEDNAX Price Targets
Multiple analysts have issued price targets for $MD recently. We have seen 3 analysts offer price targets for $MD in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $24.0 on 11/10/2025
- A.J. Rice from UBS set a target price of $23.0 on 11/05/2025
- Whit Mayo from Leerink Partners set a target price of $17.0 on 09/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
